Table of Content



Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Product
1.1.2 End Use
1.1.3 Regional Scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis (Model 1)
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.2 Volume Price Analysis (Model 2)
1.7.2.1 Approach 2: Volume Price Analysis
1.8 List Of Secondary Sources
1.9 List Of Primary Sources
1.10 List Of Abbreviations
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.11.3 Objective 3
1.11.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Penetration & Growth Prospect Mapping
2.3 Major Deals And Strategic Alliances Analysis
2.3.1 Strategic Initiatives And Outcome Analysis
2.4 Market Entry Strategies
2.4.1 Innovation/Oem
2.4.2 Product Launch
2.5 Consumer Behavior Analysis
2.6 Market Dynamics
2.6.1 Market Driver Analysis
2.6.1.1 Increasing Prevalence Of Parkinson’s Disease
2.6.1.2 Rapidly Aging Population
2.6.1.3 Technological Advancement
2.6.1.4 Increasing Preference For Targeted Therapy Approach
2.6.2 Market Restraints Analysis
2.6.2.1 Complex Regulatory Framework
2.6.2.2 Risks Of Dbs Surgery
2.6.3 Market Challenges Analysis
2.6.3.1 Lack Of Infrastructure In Developing Economies
2.7 Deep Brain Stimulation In Parkinson’s Disease Market: Market Analysis Tools
2.7.1 Industry Analysis - Porter’s
2.7.2 Swot Analysis, By Pest
2.8 Political And Legal
2.8.1 Strengths
2.8.2 Weaknesses
2.8.3 Opportunities
2.8.4 Threats
2.9 Economic
2.9.1 Strengths
2.9.2 Weaknesses
2.9.3 Opportunities
2.9.4 Threats
2.10 Technological
2.10.1 Strengths
2.10.2 Weaknesses
2.10.3 Opportunities
2.10.4 Threats
2.11 Deep Brain Stimulation In Parkinson’s Disease Market, By Product: Comparative Analysis
Chapter 3 Regulatory And Political Forces
3.1 Regulatory Landscape
3.1.1 List Of Regulations, By Country
3.2 Political Landscape, Current And Future Scenario
3.2.1 North America
3.2.2 Europe
3.2.3 Asia Pacific
3.2.4 Latin America
3.2.5 Middle East And Africa
Chapter 4 Deep Brain Stimulation In Parkinson’s Disease Market: Segment Analysis, By Product, 2016 - 2028 (USD Million)
4.1 Definition And Scope
4.2 Product Market Share Analysis, 2019 & 2028
4.3 Segment Dashboard
4.4 Global Deep Brain Stimulation In Parkinson’s Disease Market, By Product, 2016 To 2028
4.5 Market Size & Forecasts And Trend Analyses, 2016 To 2028
4.5.1 Single Channel Deep Brain Stimulator
4.5.1.1 Single Channel Deep Brain Stimulator Market, 2016 - 2028 (USD Million)
4.5.2 Dual Channel Deep Brain Stimulator
4.5.2.1 Dual Channel Deep Brain Stimulator Market, 2016 - 2028 (USD Million)
Chapter 5 Deep Brain Stimulation In Parkinson’s Disease Market: Segment Analysis, By End Use, 2016 - 2028 (USD Million)
5.1 Definition And Scope
5.2 End Use Market Share Analysis, 2019 & 2028
5.3 Segment Dashboard
5.4 Global Deep Brain Stimulation In Parkinson’s Disease Market, By End Use, 2016 To 2028
5.5 Market Size & Forecasts And Trend Analyses, 2016 To 2028
5.5.1 Hospitals
5.5.1.1 Hospitals Market, 2016 - 2028 (USD Million)
5.5.2 Neurology Clinics
5.5.2.1 Neurology Clinics Market, 2016 - 2028 (USD Million)
5.5.3 Ambulatory Surgical Centers
5.5.3.1 Ambulatory Surgical Centers Market, 2016 - 2028 (USD Million)
5.5.4 Research Centers
5.5.4.1 Research Centers Market, 2016 - 2028 (USD Million)
Chapter 6 Deep Brain Stimulation In Parkinson’s Disease Market: Regional Market Analysis, By Product, By End Use, 2016 - 2028 (USD Million)
6.1 Definition & Scope
6.2 Regional Market Share Analysis, 2019 & 2028
6.3 Regional Market Snapshot
6.4 Market Size, & Forecasts, Volume And Trend Analysis, 2016 To 2028
6.5 North America
6.5.1 North America Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.5.2 U.S.
6.5.2.1 U.S. Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.5.3 Canada
6.5.3.1 Canada Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.6 Europe
6.6.1 Europe Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.6.2 U.K.
6.6.2.1 U.K. Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.6.3 Germany
6.6.3.1 Germany Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.6.4 France
6.6.4.1 France Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.6.5 Italy
6.6.5.1 Italy Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.6.6 Spain
6.6.6.1 Spain Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.7 Asia Pacific
6.7.1 Asia Pacific Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.7.2 Japan
6.7.2.1 Japan Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.7.3 China
6.7.3.1 China Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.8 Latin America
6.8.1 Latin America Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.8.2 Brazil
6.7.2.1 Brazil Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.8.3 Mexico
6.8.3.1 Mexico Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.9 Middle East And Africa
6.9.1 Middle East And Africa Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.9.2 Saudi Arabia
6.9.2.1 Saudi Arabia Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
6.9.3 South Africa
6.9.3.1 South Africa Deep Brain Stimulation In Parkinson’s Disease Market, 2016 - 2028 (USD Million)
Chapter 7 Deep Brain Stimulation In Parkinson’s Disease Market - Competitive Analysis
7.1 Global Market Share Analysis (2019)
7.2 Product/Technology Pipeline Analysis (2020 To 2028) And New Innovations
7.2.1 Product Pipeline Analysis
7.2.2 Ongoing Research/ Innovations
7.3 Company Profiles
7.3.1 ABBOTT (ST. JUDE MEDICAL)
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.3.1 Product Price
7.3.1.4 Strategic Initiatives
7.3.2 MEDTRONIC
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product/Service Benchmarking
7.3.2.3.1 Product Price
7.3.2.4 Strategic Initiatives
7.3.3 BOSTON SCIENTIFIC CORPORATION
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product/Service Benchmarking
7.3.3.3.1 Product Price
7.3.3.4 Strategic Initiatives



List of Tables



Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. Phase 1 Clinical Trials
Table 4. Phase 2 Clinical Trials
Table 5. Phase 3 Clinical Trials
Table 6. Phase 4 Clinical Trials
Table 7. North America Deep brain stimulation in Parkinson’s disease market, by country, 2016 - 2028 (USD Million)
Table 8. North America Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 9. North America Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 10. U.S. Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 11. U.S. Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 12. Canada Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 13. Canada Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 14. Europe Deep brain stimulation in Parkinson’s disease market, by country, 2016 - 2028 (USD Million)
Table 15. Europe Deep brain stimulation in Parkinson’s disease market, by product design, 2016 - 2028 (USD Million)
Table 16. Europe Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 17. U.K. Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 18. U.K. Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 19. Germany Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 20. Germany Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 21. France Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 22. France Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 23. Italy Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 24. Italy Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 25. Spain Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 26. Spain Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 27. Asia Pacific Deep brain stimulation in Parkinson’s disease market, by country, 2016 - 2028 (USD Million)
Table 28. Asia Pacific Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 29. Asia Pacific Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 30. China Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 31. China Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 32. Japan Deep brain stimulation in Parkinson’s disease market, by product design, 2016 - 2028 (USD Million)
Table 33. Japan Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 34. Japan Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 35. Latin America Deep brain stimulation in Parkinson’s disease market, by country, 2016 - 2028 (USD Million)
Table 36. Latin America Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 37. Latin America Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 38. Brazil Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 39. Brazil Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 40. Mexico Deep brain stimulation in Parkinson’s disease market, by product design, 2016 - 2028 (USD Million)
Table 41. Mexico Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 42. Mexico Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 43. Middle East & Africa Deep brain stimulation in Parkinson’s disease market, by country, 2016 - 2028 (USD Million)
Table 44. Middle East & Africa Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 45. Middle East & Africa Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 46. South Africa Deep brain stimulation in Parkinson’s disease market, by product design, 2016 - 2028 (USD Million)
Table 47. South Africa Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 48. South Africa Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)
Table 49. Saudi Arabia Deep brain stimulation in Parkinson’s disease market, by product, 2016 - 2028 (USD Million)
Table 50. Saudi Arabia Deep brain stimulation in Parkinson’s disease market, by end use, 2016 - 2028 (USD Million)